MARKET

VXRT

VXRT

Vaxart Inc
NASDAQ
0.7251
-0.0049
-0.67%
After Hours: 0.7107 -0.0144 -1.99% 16:41 02/19 EST
OPEN
0.7160
PREV CLOSE
0.7300
HIGH
0.7440
LOW
0.7030
VOLUME
1.25M
TURNOVER
--
52 WEEK HIGH
1.540
52 WEEK LOW
0.5200
MARKET CAP
164.95M
P/E (TTM)
-1.7343
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VXRT last week (0210-0214)?
Weekly Report · 2d ago
Weekly Report: what happened at VXRT last week (0203-0207)?
Weekly Report · 02/10 10:01
Weekly Report: what happened at VXRT last week (0127-0131)?
Weekly Report · 02/03 10:03
Vaxart Announces Board Changes with New Appointment
TipRanks · 01/28 13:46
Vaxart appoints Kevin Finney to board of directors
TipRanks · 01/28 13:21
VAXART APPOINTS SEASONED BIOTECH EXECUTIVE KEVIN FINNEY TO BOARD OF DIRECTORS
Reuters · 01/28 13:00
Press Release: Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors
Dow Jones · 01/28 13:00
Weekly Report: what happened at VXRT last week (0120-0124)?
Weekly Report · 01/27 10:05
More
About VXRT
Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) proprietary oral vaccine platform. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its development programs include pill vaccines designed to protect against norovirus (cause for acute gastroenteritis), coronavirus, including SARS-CoV-2 (COVID-19)), and influenza. In addition, it has generated preclinical data for its therapeutic vaccine candidate targeting cervical cancer and dysplasia caused by human papillomavirus. The Company's platform technology employs a vector-based approach and consists of various components, such as a vector (adenovirus type 5 (Ad5); an antigen (Ad5 DNA); an adjuvant (Toll-like receptor 3 (TLR3)), and its proprietary enteric-coated tablet.

Webull offers Vaxart Inc stock information, including NASDAQ: VXRT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VXRT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VXRT stock methods without spending real money on the virtual paper trading platform.